Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

VGHCX vs HELX overlap: 15% of top holdings shared

Bottom line

How much do VGHCX and HELX overlap?

15% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 19.4% of VGHCX's assets and 11.8% of HELX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

VGHCXHELX
Weight overlap (top 25)15%
Shared holdings5
Weight in shared holdings19.4%11.8%
Total positions9763
Expense ratio0.33%0.5%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings VGHCX and HELX have in common

Holding% of VGHCX% of HELXOverlap
Eli Lilly & Co8.61%2.95%2.95%
AstraZeneca PLC4.59%2.70%2.70%
Vertex Pharmaceuticals Inc2.36%2.75%2.36%
Regeneron Pharmaceuticals Inc2.14%1.80%1.80%
Argenx SE1.68%1.64%1.64%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in VGHCX

  1. Merck & Co Inc — 5.44%
  2. Johnson & Johnson — 4.83%
  3. UnitedHealth Group Inc — 4.05%
  4. Gsk Plc — 3.00%
  5. Edwards Lifesciences Corp — 2.56%
  6. Intuitive Surgical Inc — 2.52%
  7. CVS Health Corp — 2.52%
  8. Cencora Inc — 2.47%
  9. AbbVie Inc — 2.30%
  10. Danaher Corp — 2.18%
  11. Novartis AG — 1.91%
  12. Elevance Health Inc — 1.83%
  13. HCA Healthcare Inc — 1.68%
  14. Ucb Sa — 1.67%
  15. Boston Scientific Corp — 1.53%

Only in HELX

  1. Guardant Health Inc — 9.09%
  2. Natera Inc — 7.46%
  3. Krystal Biotech Inc — 6.33%
  4. Ligand Pharmaceuticals Inc — 4.62%
  5. Adaptive Biotechnologies Corp — 3.99%
  6. United Therapeutics Corp — 3.51%
  7. Bridgebio Pharma Inc — 3.50%
  8. Twist Bioscience Corp — 2.85%
  9. Travere Therapeutics Inc — 2.59%
  10. Insmed Inc — 2.44%
  11. Samsung Biologics Co Ltd — 2.26%
  12. Corteva Inc — 2.25%
  13. Medpace Holdings Inc — 2.15%
  14. Alnylam Pharmaceuticals Inc — 1.96%
  15. Tempus Ai Inc — 1.95%

Asset mix

Asset typeVGHCXHELX
Stocks97.6%97.9%
Repurchase agreements2.2%—
Preferred stock—0.9%
Cash & short-term funds0.1%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryVGHCXHELX
US77.6%86.6%
GB7.6%3.0%
JP4.8%—
CH4.5%1.2%
BE3.4%—
KR—2.6%
DE—2.2%
NL—2.1%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do VGHCX and HELX overlap?
About 15% by weight. 5 securities appear in both funds' top 25 holdings; they make up 19.4% of VGHCX's assets and 11.8% of HELX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do VGHCX and HELX have in common?
The largest shared holdings are Eli Lilly & Co, AstraZeneca PLC, Vertex Pharmaceuticals Inc, Regeneron Pharmaceuticals Inc, Argenx SE.
Should I own both VGHCX and HELX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, VGHCX or HELX?
VGHCX is broader, with 97 positions versus 63 for HELX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.